Gritstone Bio Debt to Equity

The latest debt-to-equity ratio for GRTS is 2.18. That is above the Healthcare sector average of 0.28. Investors often review this figure alongside Gritstone Bio's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, GRTS currently prints 2.18 for debt-to-equity ratio, while the sector average sits near 0.28. That is roughly 688.2% above the sector mean. Large gaps often invite a closer look at Gritstone Bio's growth, margins, and balance sheet.

A debt-to-equity ratio of 2.18 for Gritstone Bio is not 'good' or 'bad' on its own. Compare it with the peer average (0.28) and with GRTS's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting GRTS's debt-to-equity ratio (2.18), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Gritstone Bio's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.